39 results for "Minssen, Timo"
Showing 1–20 · 0.46 seconds · RSS
-
Journal Article Full text
Navigating the EU AI Act: implications for regulated digital medical products
The newly adopted EU AI Act represents a pivotal milestone that heralds a new era of AI regulation across industries. With its broad territorial scope and applicability, this comprehensive legislation establishes stringent requirements for AI systems. In this article, we analyze the AI Act’s impact…
-
Journal Article Full text
Ethical and legal challenges of artificial intelligence-driven healthcare
This chapter will map the ethical and legal challenges posed by artificial intelligence (AI) in healthcare and suggest directions for resolving them. Section 1 will briefly clarify what AI is and Section 2 will give an idea of the trends and strategies in the United States (US) and Europe, thereby…
-
Journal Article Full text
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals covered by statutory health…
-
Journal Article Full text
The new EU–US data protection framework’s implications for healthcare
In July 2023, the United States and the European Union introduced the Data Privacy Framework (DPF), introducing the third generation of cross-border data transfer agreements constituting adequacy with respect to personal data transfers under the General Data Protection Regulation (GDPR) between the…
-
Journal Article Full text
Fighting falsified medicines with paperwork – a historic review of Danish legislation governing distribution of medicines
BACKGROUND: Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation and cross-border complexities. This study, however, focuses on an increasingly…
-
Journal Article Full text
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships
Collaboration is central for initiatives and efforts in the race to fight COVID-19, with particular focus on fostering rapid development of safe and effective COVID-19 vaccines. We investigated the types of partnerships that have emerged during the pandemic to develop these products. Using the…
-
Journal Article Full text
Quantum cryptography and data protection for medical devices before and after they meet Q-Day
Although still at a nascent state, quantum computing promises advances in healthcare, from drug discovery to personalised treatments. But it also threatens current cryptographic systems that protect medical data and infrastructure. The concept of “Q-Day” highlights risks such as “harvest now…
-
Journal Article Full text
The future of AI regulation in drug development: a comparative analysis
As artificial intelligence (AI) transforms drug development, regulatory frameworks are evolving to oversee its implementation, particularly at the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This paper makes three contributions to understanding emerging regulatory…
-
Journal Article Full text
3D Printing, Intellectual Property Rights and Medical Emergencies: In Search of New Flexibilities
The COVID-19 pandemic has exponentially accelerated the use of 3D printing (3DP) technologies in healthcare. Surprisingly, though, we have seen hardly any public intellectual property right (IPR) disputes concerning the 3D-printed medical equipment produced to cope with this crisis. Yet it can be…
-
Journal Article Full text
Use of Artificial Intelligence in Drug Development
This cross-sectional study investigates the scope and breadth of artificial intelligence use in drug development.
-
Journal Article Full text
Regulatory responses to medical machine learning
Companies and healthcare providers are developing and implementing new applications of medical artificial intelligence, including the artificial intelligence sub-type of medical machine learning (MML). MML is based on the application of machine learning (ML) algorithms to automatically identify…
-
Journal Article Full text
Shadow Health Records Meet New Data Privacy Laws
Large sets of health data can enable innovation and quality measurement but can also create technical challenges and privacy risks. When entities such as health plans and health care providers handle personal health information, they are often subject to data privacy regulation. But amid a flood of…
-
Journal Article Full text
Legal, ethical, and wider implications of suicide risk detection systems in social media platforms
Suicide remains a problem of public health importance worldwide. Cognizant of the emerging links between social media use and suicide, social media platforms, such as Facebook, have developed automated algorithms to detect suicidal behavior. While seemingly a well-intentioned adjunct to public…
-
Journal Article Full text
Patient-centric federated learning: automating meaningful consent to health data sharing with smart contracts
Federated Learning (FL) promises to enhance data-driven health research by enabling collaborative machine learning across distributed datasets without direct data exchange. However, current FL implementations primarily reflect the data-sharing interests of institutional controllers rather than…
-
Journal Article Full text
Surgeons’ Perspectives on Liability for the Use of Artificial Intelligence Technologies in the United States and European Union: Results From a Focus Group Study
OBJECTIVE: To examine surgeons’ perspectives on liability for using artificial intelligence (AI)-driven technologies in surgery in the United States and the European Union. BACKGROUND: The introduction of AI-driven technologies in surgery can improve surgical performance and patient outcomes…
-
Journal Article Full text
The impacts of pricing and reimbursement policies on access to cell and gene therapies across Europe
The increasing number of expensive cell- and gene-based therapies (CGT) on the market have raised concerns regarding equal patient access, regarding both affordability and timely access. Health Technology Assessments (HTA) and Managed Entry Agreements (MEA) play a pivotal role in pricing and…
-
Journal Article Full text
A policy framework for leveraging generative AI to address enduring challenges in clinical trials
Can artificial intelligence improve clinical trial design? Despite their importance in medicine, over 40% of trials involve flawed protocols. We introduce and propose the development of application-specific language models (ASLMs) for clinical trial design across three phases: ASLM development by…
-
Journal Article Full text
Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns
Gene-editing technology, such as CRISPR/Cas9, holds great promise for the advancement of science and many useful applications technology. This foundational technology enables modification of the genetic structure of any living organisms with unprecedented precision. Yet, in order to enhance its…